查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1938737

2026年全球兽医分子诊断市场报告

Veterinary Molecular Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，兽医分子诊断市场成长显着，预计到2025年将达到7亿美元，到2026年将达到7.7亿美元，复合年增长率为9.9%。过去几年的增长可归因于多种因素，例如动物感染疾病和遗传疾病的增加、分子生物学领域的技术进步、伴侣动物和牲畜数量的增长、兽医意识和教育的提高以及传统分子诊断试剂盒的普及应用。

预计未来几年，兽医分子诊断市场将维持强劲成长，2030年市场规模将达到11.1亿美元，复合年增长率（CAGR）为9.6%。预测期内的成长要素包括：对快速、准确的分子诊断需求不断增长；次世代定序（NGS）和高通量平台的日益普及；兽医基因组学服务的扩展；人工智慧驱动的诊断分析的整合；以及对透过分子检测进行预防性兽医保健的日益重视。预测期内的主要趋势包括：基于PCR和RT-PCR的诊断方法的扩展；兽医学领域次世代定序（NGS）技术的日益普及；感染疾病多重诊断试剂盒的开发；分子诊断技术融入常规兽医保健；以及自动化和高通量分子检测解决方案的广泛应用。

预计未来通用感染疾病的高发将推动兽医分子诊断市场的成长。通用感染疾病是由细菌、病毒、寄生虫或真菌引起的感染疾病，可在动物和人类之间传播。典型的例子包括狂犬病、莱姆病、沙门氏菌病和弓形虫病。这些疾病的流行受到多种因素的影响，例如森林砍伐、野生动物过度开发、密集畜牧业、生物多样性丧失和人口流动。兽医分子诊断技术能够早期检测动物体内的通用感染疾病，透过快速且准确地鑑定病原体，有助于预防人类感染并加强疾病控制。例如，根据总部位于瑞典的政府机构－欧洲疾病预防控制中心（ECDC）2025年12月发布的报告，2024年报告的主要通用感染疾病病例数（曲状桿菌：168,396例，沙门氏菌病：79,703例等）持续增加，凸显了通用感染疾病在欧洲的持续蔓延。因此，通用感染疾病的高发生率正在推动兽医分子诊断市场的发展。

兽医分子诊断市场的主要企业正致力于诊断技术的自动化和扩充性，例如高通量检测设备，以提高诊断准确性、简化检测流程并快速检测动物疾病。高通量检测设备是一种先进的诊断设备，能够有效率地处理大量检体，支援实验室和临床环境中的快速且准确分析，尤其适用于大规模检测。例如，2023年6月，美国爱荷华州立大学兽医诊断实验室（VDL）推出了SmartChip分子诊断设备，该设备采用定量聚合酵素链锁反应（qPCR）技术。该设备可在邮票大小的微孔板上容纳超过5000个检体，并可与具有自动化处理功能的384检体系统结合使用，进一步提高检测通量。 SmartChip利用微流体技术，只需标准96孔盘百分之一的样本量即可高效识别目标病原体。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球兽医分子诊断市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 物联网、智慧基础设施和互联生态系统
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • PCR和RT-PCR诊断方法的扩展
    • 兽医学领域对次世代定序（NGS）技术的日益普及
    • 开发用于感染疾病的多重诊断试剂盒
    • 将分子诊断技术整合到常规兽医护理中
    • 自动化高通量分子检测解决方案

第五章 终端用户产业市场分析

  • 诊断检查室
  • 兽医诊所
  • 兽医诊所
  • 研究所
  • 学术和兽医训练中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球兽医分子诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球兽医分子诊断市场规模、比较及成长率分析
  • 全球兽医分子诊断市场表现：规模与成长，2020-2025年
  • 全球兽医分子诊断市场预测：规模与成长，2025-2030年，2035年

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 副产品
  • 试剂盒、试剂和设备
  • 依动物类型
  • 伴侣动物、牲畜
  • 透过使用
  • 感染疾病、遗传性疾病及其他用途
  • 最终用户
  • 诊断检查室、动物诊所、兽医医院和其他终端用户
  • 按类型细分：试剂盒和试剂
  • 聚合酵素链锁反应(PCR) 试剂盒、逆转录聚合酵素链锁反应(RT-PCR) 试剂盒、即时PCR盒、核酸萃取试剂盒、酵素免疫分析法(ELISA) 试剂盒、杂合反应盒和次世代定序(NGS) 试剂
  • 按类型细分：设备
  • PCR设备（聚合酵素连锁反应热迴圈仪）、即时PCR设备、核酸分析设备、凝胶电泳设备、DNA定序仪、自动化液体处理系统、分子影像系统

第十章 区域与国家分析

  • 全球兽医分子诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年、2035年
  • 全球兽医分子诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年、2035年

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 兽医分子诊断市场：竞争格局与市场占有率（2024 年）
  • 兽医分子诊断市场：公司估值矩阵
  • 兽医分子诊断市场：公司概况
    • Roche Diagnostics Corporation
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Zoetis Inc.
    • Illumina Inc.

第37章：其他领先和创新企业

  • PerkinElmer Inc., bioMerieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN NV, LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek BV, Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年兽医分子诊断市场：提供新机会的国家
  • 2030年兽医分子诊断市场：充满新机会的细分市场
  • 2030年兽医分子诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: VH4MVMDO01_G26Q1

Veterinary molecular diagnostics involves the use of molecular biology techniques to identify and diagnose animal diseases at the genetic or molecular level. These diagnostics detect specific pathogens (such as bacteria, viruses, or parasites), genetic mutations, or biomarkers that signal disease, assisting veterinarians in making precise diagnoses and treatment plans.

The main products in veterinary molecular diagnostics include kits, reagents, and instruments. Kits and reagents are crucial for conducting various diagnostic tests on animal samples in laboratories and industrial settings, providing accurate and reliable results necessary for effective treatment and management of diseases. These diagnostics are applicable to both companion animals and livestock, addressing conditions such as infectious and genetic diseases. The primary users of these products are diagnostic laboratories, veterinary clinics, veterinary hospitals, and similar facilities.

Tariffs have impacted the veterinary molecular diagnostics market by increasing the cost of imported kits, reagents, and advanced instruments such as PCR machines and DNA sequencers, affecting pricing and accessibility for diagnostic laboratories and veterinary clinics. Segments like kits and reagents and instruments are most affected, particularly in regions such as North America and Europe reliant on imports. However, tariffs have also stimulated local manufacturing, encouraged development of cost-effective diagnostic solutions, and fostered regional innovation in molecular veterinary diagnostics.

The veterinary molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary molecular diagnostics market statistics, including veterinary molecular diagnostics industry global market size, regional shares, competitors with a veterinary molecular diagnostics market share, detailed veterinary molecular diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary molecular diagnostics industry. This veterinary molecular diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary molecular diagnostics market size has grown strongly in recent years. It will grow from $0.7 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing prevalence of infectious and genetic animal diseases, technological advancements in molecular biology, growth of companion and livestock animal populations, rising veterinary awareness and training, adoption of conventional molecular diagnostic kits.

The veterinary molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $1.11 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to rising demand for rapid and accurate molecular diagnostics, adoption of ngs and high-throughput platforms, expansion of veterinary genomics services, integration of ai-driven diagnostic analysis, growing emphasis on preventive veterinary care through molecular testing. Major trends in the forecast period include expansion of pcr and rt-pcr-based diagnostics, growing adoption of next-generation sequencing (ngs) in veterinary medicine, development of multiplex diagnostic kits for infectious diseases, integration of molecular diagnostics in routine veterinary care, automation and high-throughput molecular testing solutions.

The high prevalence of zoonotic diseases is expected to drive the growth of the veterinary molecular diagnostics market going forward. Zoonotic diseases are infectious conditions transmitted between animals and humans, caused by bacteria, viruses, parasites, or fungi. Common examples include rabies, Lyme disease, salmonellosis, toxoplasmosis, and more. The prevalence of these diseases is influenced by factors such as deforestation, wildlife exploitation, intensive animal farming, biodiversity loss, and human mobility. Veterinary molecular diagnostics enable early detection of zoonotic diseases in animals, preventing transmission to humans and improving disease management through rapid and accurate pathogen identification. For example, in December 2025, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, the number of reported human cases of key zoonotic diseases in 2024-such as campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases)-continued to rise, highlighting the ongoing prevalence of zoonoses in Europe. Therefore, the high prevalence of zoonotic diseases is driving the veterinary molecular diagnostics market.

Leading players in the veterinary molecular diagnostics market are focusing on automation and scalability in diagnostic technologies, such as high-volume testing machines, to enhance diagnostic accuracy, increase testing efficiency, and enable faster disease detection in animals. High-volume testing machines are advanced diagnostic devices capable of processing large numbers of samples efficiently, supporting rapid and accurate analysis in laboratory or clinical settings, especially for large-scale testing. For instance, in June 2023, Iowa State University's Veterinary Diagnostic Laboratory (VDL), a US-based university, introduced SmartChip, a molecular diagnostic device utilizing quantitative polymerase chain reaction (qPCR) technology. This device can accommodate over 5,000 samples on a plate no larger than a postage stamp, and its capacity increases further when paired with a 384-sample system featuring automated handling. SmartChip employs microfluidic technology, using a sample volume 100 times smaller than standard 96-well machines, to identify targets of interest efficiently.

In April 2023, Mars Incorporated, a US-based diversified manufacturing and petcare company, acquired Heska Corporation for approximately $1.3 billion. Through this acquisition, Mars aimed to strengthen and expand its petcare science and diagnostics capabilities by broadening its veterinary diagnostic offerings and accelerating innovation in point-of-care solutions for the global pet healthcare market. Heska Corporation is a US-based healthcare technology company specializing in the development, manufacture, marketing, and support of advanced veterinary diagnostic and specialty products for veterinary practitioners worldwide.

Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.

North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary molecular diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance testing, genetic testing, toxicology, and biocompatibility testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary molecular diagnostics market also includes sales of immunoassay kits, diagnostic software, and next-generation sequencing (NGS) systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Molecular Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Kits And Reagents; Instruments
  • 2) By Animal Type: Companion Animals; Livestock Animals
  • 3) By Application: Infectious Diseases; Genetic Diseases; Other Applications
  • 4) By End-User: Diagnostic Laboratories; Veterinary Clinics; Veterinary Hospitals; Other End-Users
  • Subsegments:
  • 1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits; Reverse Transcription PCR (RT-PCR) Kits; Real-Time PCR Kits; Nucleic Acid Extraction Kits; Enzyme-Linked Immunosorbent Assay (ELISA) Kits; Hybridization Kits; Reagents For Next-Generation Sequencing (NGS)
  • 2) By Instruments: PCR Machines (Thermal Cyclers); Real-Time PCR Machines; Nucleic Acid Analyzers; Gel Electrophoresis Equipment; DNA Sequencers; Automated Liquid Handling Systems; Molecular Imaging Systems
  • Companies Mentioned: Roche Diagnostics Corporation; Thermo Fisher Scientific Inc.; Merck KGaA; Zoetis Inc.; Illumina Inc.; PerkinElmer Inc.; bioMerieux S.A.; IDEXX Laboratories Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; LGC Group Ltd.; Neogen Corporation; Abcam plc; Eiken Chemical Co. Ltd.; Bioneer Corporation; INDICAL BIOSCIENCE GmbH; Biochek B.V.; Ring Biotechnology Co. Ltd.; Ingenetix GmbH; MiDOG Animal Diagnostics LLC; Biolab S.r.l.; Bionote USA Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Veterinary Molecular Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Veterinary Molecular Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Veterinary Molecular Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Veterinary Molecular Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Pcr And Rt-Pcr-Based Diagnostics
    • 4.2.2 Growing Adoption Of Next-Generation Sequencing (Ngs) In Veterinary Medicine
    • 4.2.3 Development Of Multiplex Diagnostic Kits For Infectious Diseases
    • 4.2.4 Integration Of Molecular Diagnostics In Routine Veterinary Care
    • 4.2.5 Automation And High-Throughput Molecular Testing Solutions

5. Veterinary Molecular Diagnostics Market Analysis Of End Use Industries

  • 5.1 Diagnostic Laboratories
  • 5.2 Veterinary Clinics
  • 5.3 Veterinary Hospitals
  • 5.4 Research Institutes
  • 5.5 Academic And Veterinary Training Centers

6. Veterinary Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Veterinary Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Veterinary Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Veterinary Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Veterinary Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Molecular Diagnostics Market Segmentation

  • 9.1. Global Veterinary Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits And Reagents, Instruments
  • 9.2. Global Veterinary Molecular Diagnostics Market, Segmentation By Animal Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Companion Animals, Livestock Animals
  • 9.3. Global Veterinary Molecular Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Genetic Diseases, Other Applications
  • 9.4. Global Veterinary Molecular Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
  • 9.5. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Kits And Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)
  • 9.6. Global Veterinary Molecular Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems

10. Veterinary Molecular Diagnostics Market Regional And Country Analysis

  • 10.1. Global Veterinary Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Veterinary Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Molecular Diagnostics Market

  • 11.1. Asia-Pacific Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Molecular Diagnostics Market

  • 12.1. China Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Molecular Diagnostics Market

  • 13.1. India Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Molecular Diagnostics Market

  • 14.1. Japan Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Molecular Diagnostics Market

  • 15.1. Australia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Molecular Diagnostics Market

  • 16.1. Indonesia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Molecular Diagnostics Market

  • 17.1. South Korea Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Molecular Diagnostics Market

  • 18.1. Taiwan Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Molecular Diagnostics Market

  • 19.1. South East Asia Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Molecular Diagnostics Market

  • 20.1. Western Europe Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Molecular Diagnostics Market

  • 21.1. UK Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Molecular Diagnostics Market

  • 22.1. Germany Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Molecular Diagnostics Market

  • 23.1. France Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Molecular Diagnostics Market

  • 24.1. Italy Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Molecular Diagnostics Market

  • 25.1. Spain Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Molecular Diagnostics Market

  • 26.1. Eastern Europe Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Molecular Diagnostics Market

  • 27.1. Russia Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Molecular Diagnostics Market

  • 28.1. North America Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Molecular Diagnostics Market

  • 29.1. USA Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Molecular Diagnostics Market

  • 30.1. Canada Veterinary Molecular Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Molecular Diagnostics Market

  • 31.1. South America Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Molecular Diagnostics Market

  • 32.1. Brazil Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Molecular Diagnostics Market

  • 33.1. Middle East Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Molecular Diagnostics Market

  • 34.1. Africa Veterinary Molecular Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Veterinary Molecular Diagnostics Market, Segmentation By Product, Segmentation By Animal Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Molecular Diagnostics Market Regulatory and Investment Landscape

36. Veterinary Molecular Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Veterinary Molecular Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Veterinary Molecular Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Veterinary Molecular Diagnostics Market Company Profiles
    • 36.3.1. Roche Diagnostics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Molecular Diagnostics Market Other Major And Innovative Companies

  • PerkinElmer Inc., bioMerieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC

38. Global Veterinary Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Molecular Diagnostics Market

40. Veterinary Molecular Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Veterinary Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Veterinary Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Veterinary Molecular Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer